Medicine Man Technologies Inc SHWZ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SHWZ is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.65
- Day Range
- $0.65–0.67
- 52-Week Range
- $0.48–1.55
- Bid/Ask
- $0.56 / $0.80
- Market Cap
- $50.68 Mil
- Volume/Avg
- 13,276 / 64,286
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.25
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.22%
Company Profile
Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company’s business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 840
- Website
- https://www.schwazze.com
Comparables
Valuation
|
Metric
|
SHWZ
|
CL
|
VRNO
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 0.42 | 1.43 | 1.43 |
Price/Sales | 0.25 | 0.88 | 1.85 |
Price/Cash Flow | — | 15.60 | 15.82 |
Price/Earnings
SHWZ
CL
VRNO
Financial Strength
|
Metric
|
SHWZ
|
CL
|
VRNO
|
|---|---|---|---|
Quick Ratio | 0.43 | 0.78 | 0.52 |
Current Ratio | 0.97 | 1.39 | 0.96 |
Interest Coverage | 0.54 | −1.36 | 1.46 |
Quick Ratio
SHWZ
CL
VRNO
Profitability
|
Metric
|
SHWZ
|
CL
|
VRNO
|
|---|---|---|---|
Return on Assets (Normalized) | −11.32% | −3.12% | −2.28% |
Return on Equity (Normalized) | −29.05% | −8.02% | −4.10% |
Return on Invested Capital (Normalized) | −4.60% | −0.11% | −0.53% |
Return on Assets
SHWZ
CL
VRNO
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Rnyqqfym | Myhpmh | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Yqmywhxzp | Tlj | $68.9 Bil | |
HLN
| Haleon PLC ADR | Grqpgpjbg | Dylb | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Sytgcgjy | Fnh | $14.7 Bil | |
VTRS
| Viatris Inc | Jqkybby | Kbh | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hfgjlcd | Wdrh | $11.9 Bil | |
CTLT
| Catalent Inc | Jnnjpgqcw | Zyqvsd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Nrhmxqtl | Dnvh | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Dphnydqyf | Rsmj | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Tpqmkhmdv | Qsmcks | $3.5 Bil |